home.aspx
 
EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...

Aratana Therapeutics Inc.

SHARESHARESHARE
Aratana Therapeutics, Inc. (Nasdaq: PETX) is a pet therapeutics company focused on licensing, developing and commercializing innovative therapeutics for cats and dogs. Aratana is a fast-growing company headquartered in the greater Kansas City area focused on delivering safe and effective therapeutics that elevate the standard of care in veterinary medicine. As a pioneer in pet therapeutics, Aratana’s goal is to work with companion animal veterinarians to bring new therapeutics to market that support the needs of pets and their owners.
SHARESHARESHARE

RELATED NEWS


One of the most engaging areas of research these days is improving drug delivery. Here at Medgadget, we often share news about technological advances in nanomedicine that promise improved delivery to tumor sites, or newly designed gadgets that increase drug delivering efficacy. Rarely do we hear about attempts to improve drug delivery in the lungs. Recent reports suggest that almost 7% of all US deaths are due to chronic respiratory diseases, making them the fifth leading cause of death. Thankfu...

READ MORE

Pharma has called for politicians to take action to ensure patient safety in the event of a ‘no deal’ situation, after the UK parliament’s historic decision to reject prime minister Theresa May’s Brexit deal last night. May now faces a confidence vote in the House of Commons that could lead to a general election if she loses out. But amid the political chaos European pharma is calling for action to ensure patients across the EU and UK receive their medications in the case...

READ MORE

Sygnature Discovery has released a biology publication focusing on our collaboration with Corcept Therapeutics. This work highlights our biomarker validation work and reports the outcome of phase....

READ MORE

Analysts are predicting that a combination of Merck’s Keytruda and Pfizer’s Inlyta will become the standard of care in renal cell carcinoma (RCC) thanks to impressive trial results and a price advantage over BMS’ rival drug. The combination of anti-PD-1 therapy Keytruda with tyrosine kinase inhibitor Inlyta (axitinib) reduced risk of death in RCC by around 47%, compared with Pfizer’s established cancer drug Sutent (sunitinib), in phase 3 KEYNOTE-426 study – announce...

READ MORE

Researchers from RUDE University and Institute of Biomedical Chemistry of the Russian Academy of Sciences have identified an alternative mechanism for the effective antitumor drug -- an enzyme called L-asparaginase....

READ MORE

On Thursday, Shares of Pfizer Inc. (NYSE:PFE) lost -0.19% to $32.34. The share price is trading in a range of $32.05 – 32.43. The stock exchanged hands with 18.61 million shares contrast to its average daily volume of 31.10 million shares....
WWW.NEWSISMONEY.COM
READ MORE

EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...